S&P 500Dow JonesNASDAQ 100DAX 40MDAXSDAXTecDAXATXSMICAC 40AEXBEL 20IBEX 35
Home/DAX 40/Fresenius Medical Care
Fresenius Medical Care

Fresenius Medical Care

FME.DEDAX 40
39,56 €
Dividend yield3,79 %
Continuity28 yr
Dividend1,49 €
ISINDE0005785802
DiviScore
51SCOREGood
Performance3/35
Dividend Quality29/35
AGM Date
Ex-Date
22.05.2026
Payment
CAGR 3Y
-0.6%
CAGR 5Y
-9.8%
CAGR 10Y
-6.9%

€10,000 invested in 2016 · with dividend reinvestment

+-37%
End Value
6.253,75 €
Total Return
+-37.5%
Annual Return
-4.6% p.a.
Dividends Received
1.873,69 €

Dividend history

28 years continuous
YearAmountDividend yieldAGM dateEx-datePayment dateChange
20261,49 €22.05.2026+3.5%
20251,44 €21.05.202623.05.202526.05.20260.0%
20241,44 €22.05.202523.05.202527.05.2025+21.0%
20231,19 €17.04.202417.05.202416.06.2024+6.2%
20221,12 €17.04.202317.05.202316.06.2023-17.0%
20211,35 €13.04.202213.05.202212.06.2022+0.7%
20201,34 €21.04.202121.05.202120.06.2021+11.7%
20191,20 €29.07.202028.08.202027.09.2020+2.6%
20181,17 €17.04.201917.05.201916.06.2019+10.4%
20171,06 €18.04.201818.05.201817.06.2018+10.4%

Quarterly Results

38% Beat Rate
QuarterDateEPS (Est.)EPS (Actual)Surprise
Q3 202604.08.20261,07 €1,13 €+5.6%
Q2 202611.06.2026-0,33 €-0,09 €-72.7%
Q1 202624.02.20261,08 €1,44 €+33.3%
Q4 202511.12.2025-2,13 €-0,32 €-85.0%
Q3 202505.08.20251,69 €0,91 €-46.1%
Q2 202506.05.20250,60 €0,84 €+40.0%
Q1 202525.02.20251,04 €0,91 €-12.5%
Q4 202405.11.20243,25 €0,82 €-74.8%

About Fresenius Medical Care

Fresenius Medical Care AG is the world's largest dialysis company, providing comprehensive renal care services to patients globally. It operates nearly 3,700 dialysis clinics, treating approximately 300,000 patients worldwide through specialized medical services that include hemodialysis and peritoneal dialysis treatments. In addition to patient care, Fresenius Medical Care AG is a leading supplier of dialysis products such as machines, dialyzers, and concentrates, holding a significant share of the global dialysis products market and creating a fully integrated business model. Services represent the majority of its operations, complemented by medical technology products essential for dialysis procedures. The company focuses on the healthcare sector, specifically medical care facilities within the renal therapy industry, serving patients across various regions with a network of clinics and product distribution. Founded in 1996 and headquartered in Bad Homburg, Germany, Fresenius Medical Care AG plays a pivotal role in advancing dialysis treatments and supporting chronic kidney disease management.

IndustryMedical Care Facilities
SectorHealthcare
KGV (PE)11.95
Payout Ratio44.9%
ROE8.5%

Frequently Asked Questions

The next payment date is not yet announced.
Fresenius Medical Care has a DiviScore of 51/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Fresenius Medical Care's current dividend yield is 3.79% based on the latest dividend.
Fresenius Medical Care (FME.DE) is a member of DAX 40. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.